Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians
Berna-Rico, Emilio (Hospital Universitario Ramón y Cajal (Madrid))
Abbad-Jaime de Aragon, Carlota (Hospital Universitario Ramón y Cajal (Madrid))
Garcia-Aparicio, Ángel (Hospital Universitario de Toledo)
Palacios-Martinez, David (Centro de Salud Universitario Isabel II)
Ballester-Martínez, Asunción (Hospital Universitario Ramón y Cajal (Madrid))
Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
De la Cueva, Pablo (Hospital Universitario Infanta Leonor)
Anton, Cristina (Universidad Francisco de Vitoria, Madrid)
Azcarraga-Llobet, Carlos (Hospital Universitario Ramón y Cajal (Madrid))
Garcia-Mouronte, Emilio (Hospital Universitario Ramón y Cajal (Madrid))
De Nicolas-Ruanes, Belén (Hospital Universitario Ramón y Cajal (Madrid))
Puig-Verdié, Lluís (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Jaen, Pedro (Hospital Universitario Ramón y Cajal (Madrid))
Mehta, Nehal N. (National Institutes of Health (Estats Units))
Gelfand, Joel M. (University of Pennsylvania Perelman School of Medicine (Estats Units))
Gonzalez-Cantero, Álvaro (Universidad Francisco de Vitoria (Madrid))
Universitat Autònoma de Barcelona

Data:	2023
Resum:	Patients with psoriasis have a higher prevalence of cardiovascular risk factors. This study evaluated cardio-vascular screening practices and statin prescribing habits among dermatologists, rheumatologists and primary care physicians (PCPs) through an online questionnaire, which was distributed through the Spanish scientific societies of the above-mentioned specialties. A total of 299 physicians (103 dermatologists, 94 rheumatologists and 102 PCPs) responded to the questionnaire. Of these, 74. 6% reported screening for smoking, 37. 8% for hypertension, 80. 3% for dyslipidaemia, and 79. 6% for diabetes mellitus. Notably, only 28. 4% performed global screening, defined as screening for smoking, hypertension, dyslipidaemia, and diabetes mellitus by the same physician, and 24. 4% reported calculating 10-year cardiovascular disease (CVD) risk, probably reflecting a lack of comprehensive cardiovascular risk assessment in these patients. This study also identified unmet needs for awareness of cardiovascular comorbidities in psoriasis and corresponding screening and treatment recommendations among PCPs. Of PCPs, 61. 2% reported not being aware of the association between psoriasis and CVD and/or not being aware of its screening recommendations, and 67. 6% did not consider psoriasis as a risk-enhancing factor when deciding on statin prescription. Thirteen dermatologists (12. 6%) and 35 rheumatologists (37. 2%) reported prescribing statins. Among those who do not prescribe, 49. 7% would be willing to start their prescription.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Cardiovascular disease ; Diagnosis ; Hearth disease risk factor ; Psoriasis
Publicat a:	Acta dermato-venereologica, Vol. 103 (march 2023) , ISSN 1651-2057

DOI: 10.2340/actadv.v103.5087
PMID: 36987537

8 p, 492.9 KB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
Articles > Articles de recerca
Articles > Articles publicats